Domínguez JL - Search Results

1

Effect of pH and ligand charge state on BACE-1 fragment docking performance.

Domínguez JL, Villaverde MC, Sussman F. Domínguez JL, et al. J Comput Aided Mol Des. 2013 May;27(5):403-17. doi: 10.1007/s10822-013-9653-7. Epub 2013 May 3. J Comput Aided Mol Des. 2013. PMID: 23640428

2

Effect of the protonation state of the titratable residues on the inhibitor affinity to BACE-1.

Domínguez JL, Christopeit T, Villaverde MC, Gossas T, Otero JM, Nyström S, Baraznenok V, Lindström E, Danielson UH, Sussman F. Domínguez JL, et al. Biochemistry. 2010 Aug 31;49(34):7255-63. doi: 10.1021/bi100637n. Biochemistry. 2010. PMID: 20687525

3

On a possible neutral charge state for the catalytic dyad in β-secretase when bound to hydroxyethylene transition state analogue inhibitors.

Sussman F, Otero JM, Villaverde MC, Castro M, Domínguez JL, González-Louro L, Estévez RJ, Estévez JC. Sussman F, et al. Among authors: dominguez jl. J Med Chem. 2011 Apr 28;54(8):3081-5. doi: 10.1021/jm101568y. Epub 2011 Mar 31. J Med Chem. 2011. PMID: 21452857

4

Experimental and 'in silico' analysis of the effect of pH on HIV-1 protease inhibitor affinity: implications for the charge state of the protein ionogenic groups.

Domínguez JL, Gossas T, Carmen Villaverde M, Helena Danielson U, Sussman F. Domínguez JL, et al. Bioorg Med Chem. 2012 Aug 1;20(15):4838-47. doi: 10.1016/j.bmc.2012.05.070. Epub 2012 Jun 7. Bioorg Med Chem. 2012. PMID: 22743085

5

On the active site protonation state in aspartic proteases: implications for drug design.

Sussman F, Villaverde MC, Domínguez JL, Danielson UH. Sussman F, et al. Among authors: dominguez jl. Curr Pharm Des. 2013;19(23):4257-75. doi: 10.2174/1381612811319230009. Curr Pharm Des. 2013. PMID: 23170891 Review.

6

Computer-aided structure-based design of multitarget leads for Alzheimer's disease.

Domínguez JL, Fernández-Nieto F, Castro M, Catto M, Paleo MR, Porto S, Sardina FJ, Brea JM, Carotti A, Villaverde MC, Sussman F. Domínguez JL, et al. J Chem Inf Model. 2015 Jan 26;55(1):135-48. doi: 10.1021/ci500555g. Epub 2014 Dec 24. J Chem Inf Model. 2015. PMID: 25483751

7

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.

Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.

8

Infiltrative endometriosis without endometrioma: A case report and imaging findings mimicking a bladder malignancy.

Dominguez JL, Mattinson TJ, Wang SS, Revels JW. Dominguez JL, et al. Radiol Case Rep. 2021 Oct 29;17(1):41-45. doi: 10.1016/j.radcr.2021.09.059. eCollection 2022 Jan. Radiol Case Rep. 2021. PMID: 34765057 Free PMC article.

9

Survival and glycemic control in patients with co-existing squamous cell carcinoma and diabetes mellitus.

Ederaine SA, Dominguez JL, Harvey JA, Mangold AR, Cook CB, Kosiorek H, Buras M, Coppola K, Karlin NJ. Ederaine SA, et al. Among authors: dominguez jl. Future Sci OA. 2021 Feb 10;7(5):FSO683. doi: 10.2144/fsoa-2020-0150. Future Sci OA. 2021. PMID: 34046188 Free PMC article.

10

Report of the President of the AECP.

de la Portilla F, Arroyo A, Calderón T, Domínguez JL, Espí A, Farrés R, García AM, Jiménez F, Parajó A, Perea J, Parra P, García-Armengol J. de la Portilla F, et al. Among authors: dominguez jl. Colorectal Dis. 2021 May;23(5):1059. doi: 10.1111/codi.15629. Colorectal Dis. 2021. PMID: 33970529 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page